Trial Details

COMPLETED
Basic Information
Clinical ID c2822
Identifier NCT02914262
Trial Title Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions IBD
Interventions DRUG: AKB-4924|OTHER: Placebo
Participant Information
Sponsor Aerpio Therapeutics
City Toronto
Country/Region Canada
Enrollment Criteria
Sex Requirement MALE
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2016-08
Primary Completion Date 2016-11
Completion Date 2017-01